Company intelligence / Profile preview

Vision Opportunity Master Fund

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Vision Opportunity Master Fund was a New York-based hedge fund managed by Vision Capital Advisors that specialized in Private Investment in Public Equity (PIPE) transactions. The fund was a prominent financier for micro-cap and small-cap companies, with a significant portion of its portfolio dedicated to the life sciences, biotechnology, and healthcare industries. It provided essential growth capital to emerging biotech firms to support their clinical trials and research initiatives. The fund ceased active operations following legal and regulatory actions involving its founder in the mid-2010s. It is primarily recognized in the life sciences sector as a financial vehicle rather than a drug developer.

Industry: Investors

Beyond the preview

Go deeper on Vision Opportunity Master Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vision Opportunity Master Fund.

Explore the full profile